Aerie Pharmaceuticals
| Use attributes for filter ! | |
| Stock price | AERI |
|---|---|
| Disclaimer | |
| Headquarters | North Carolina |
| United States | |
| Ceo | Vicente Anido Jr |
| Presidents | Thomas A. Mitro |
| CFO | Richard J. Rubino |
| General counsel | John W. LaRocca |
| Subsidiaries | Avizorex Pharma, SL |
| Aerie Pharmaceuticals Limited | |
| Aerie Distribution Incorporated | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2326823 |
About Aerie Pharmaceuticals
Aerie Pharmaceuticals Inc. is a publicly traded, clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
